Methylamine → 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-chloro-5,6-dihydro-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one
반응식
[Cl:1][C:2]1[C:7]2[C:8](=[O:34])[N:9]([CH3:33])[CH2:10][C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]3[O:20][N:19]=[C:18]([CH2:21][N:22]4C(=O)C5=CC=CC=C5C4=O)[N:17]=3)[C:6]=2[CH:5]=[CH:4][CH:3]=1.CN>C(O)C>[NH2:22][CH2:21][C:18]1[N:17]=[C:16]([C:15]2[N:14]=[CH:13][N:12]3[C:6]4[CH:5]=[CH:4][CH:3]=[C:2]([Cl:1])[C:7]=4[C:8](=[O:34])[N:9]([CH3:33])[CH2:10][C:11]=23)[O:20][N:19]=1참가 물질
실험 절차
35.1 g (74 mmol) of 7-chloro-5,6-dihydro-5-methyl-3-(3-phthalimidomethyl-1,2,4-oxadiazol-5-yl)-4H-imidazo[1,5-a]-[1,4]benzodiazepin-6-one were stirred with 190 ml of methylamine in ethanol) and 100 ml of ethanol at 80° for 3 hours. The solution was concentrated, the residue was taken up in methylene chloride and 100 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride. The aqueous phase was made alkaline with 105 ml of 4N sodium hydroxide solution and extracted six times with methylene chloride. After drying the combined organic solutions and evaporating the solvent there were obtained 18.14 g (71%) of 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-chloro-5,6-dihydro-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one, which was used without further purification as the starting material for the Example described hereinafter.
후처리
- concentrationThe solution was concentrated
- wash100 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride
- extractionextracted six times with methylene chloride
- customAfter drying the combined organic solutions
- customevaporating the solvent there
출처 및 근거
- ORD 기록
- ord-39cce4b912134223a80a16acd9cce2c1
- 출처 데이터셋
- uspto-grants-1997_09
- 특허 번호
- US05665718
반응 노트
불러오는 중…